Seeking Alpha

Salix Pharmaceuticals (SLXP): Q4 EPS of $0.66 beats by $0.17. Revenue of $118.5M (+69% Y/Y)...

Salix Pharmaceuticals (SLXP): Q4 EPS of $0.66 beats by $0.17. Revenue of $118.5M (+69% Y/Y) in-line. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)